Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
  • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
  • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
  • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D263/18—Oxygen atoms
  • C07D263/20—Oxygen atoms attached in position 2
  • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/42—Oxazoles
  • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/24—Antidepressants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/02—Local antiseptics
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Applications Claiming Priority (3)

Publications (1)

Family

ID=44115617

Family Applications (1)

Country Status (27)

Families Citing this family (1)

Family Cites Families (7)

• 2012
  • 2012-01-17 CA CA2817462A patent/CA2817462C/en active Active
  • 2012-01-17 SI SI201230789A patent/SI2670737T1/sl unknown
  • 2012-01-17 SG SG10201600357WA patent/SG10201600357WA/en unknown
  • 2012-01-17 HU HUE12700288A patent/HUE029476T2/en unknown
  • 2012-01-17 CN CN201280004303.XA patent/CN103298797B/zh active Active
  • 2012-01-17 WO PCT/EP2012/050609 patent/WO2012104139A1/en active Application Filing
  • 2012-01-17 EP EP12700288.9A patent/EP2670737B1/en active Active
  • 2012-01-17 JP JP2013550823A patent/JP2014503564A/ja active Pending
  • 2012-01-17 UA UAA201305952A patent/UA114593C2/uk unknown
  • 2012-01-17 ES ES12700288.9T patent/ES2605425T3/es active Active
  • 2012-01-17 SG SG2013055991A patent/SG192090A1/en unknown
  • 2012-01-17 AU AU2012213666A patent/AU2012213666B2/en active Active
  • 2012-01-17 GE GEAP201213202A patent/GEP20156352B/en unknown
  • 2012-01-17 MX MX2013008426A patent/MX339346B/es active IP Right Grant
  • 2012-01-17 DK DK12700288.9T patent/DK2670737T3/en active
  • 2012-01-17 LT LTEP12700288.9T patent/LT2670737T/lt unknown
  • 2012-01-17 EA EA201390787A patent/EA024417B1/ru unknown
  • 2012-01-17 PT PT127002889T patent/PT2670737T/pt unknown
  • 2012-01-17 US US13/990,974 patent/US20130261160A1/en not_active Abandoned
  • 2012-01-17 PL PL12700288T patent/PL2670737T3/pl unknown
  • 2012-01-17 BR BR112013013134-9A patent/BR112013013134B1/pt active IP Right Grant
  • 2012-01-17 KR KR1020137016255A patent/KR101907599B1/ko active IP Right Grant
  • 2012-01-30 AR ARP120100285A patent/AR084946A1/es active IP Right Grant
• 2013
  • 2013-05-13 IL IL226329A patent/IL226329A/en active IP Right Grant
• 2014
  • 2014-04-30 HK HK14104176.2A patent/HK1191006A1/zh unknown
• 2015
  • 2015-06-17 US US14/742,203 patent/US9416116B2/en active Active
• 2016
  • 2016-11-15 SM SM201600415T patent/SMT201600415B/it unknown
  • 2016-12-01 CY CY20161101242T patent/CY1118348T1/el unknown
  • 2016-12-06 HR HRP20161660TT patent/HRP20161660T1/hr unknown

Also Published As

Similar Documents